BioStable Science & Engineering
designs, develops and commercializes cardiovascular devices for the treatment of aortic valve diseases... Read moreBioStable Science & Engineering
designs, develops and commercializes cardiovascular devices for the treatment of aortic valve diseases... Read more
News
Aug 09, 2021
NS Medical Devices
BioStable Science & Engineering: BioStable Science & Engineering Initiates European Commercialisation of the HAART 200 Aortic Annuloplasty Device
Aug 06, 2021
Medical Device News Magazine
BioStable Science & Engineering: HAART 200 Aortic Annuloplasty Device: 1st European Commercialization Implantation Reported
Apr 22, 2021
NS Medical Devices
BioStable Science & Engineering: BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device
Mar 11, 2020
Statesman
BioStable Science & Engineering: Austin biotech firm Biostable raises $4.2 million
Feb 25, 2020
BioPortfolio
BioStable: BioStable Science & Engineering Announces Initial Closing of Series C Equity Round
May 03, 2019
BioPortfolio
BioStable: BioStable Science & Engineering Surpasses 500 Patients Treated Worldwide with the HAART Devices
May 07, 2018
Machine Design
BioStable: Polymer Used for Reusable Tool that Sizes Patients' Aortic Valves
May 03, 2018
British Plastics and Rubber
BioStable: Radel PPSU from Solvay applied to BioStable Annuloplasty device
Oct 11, 2017
Medical Product Outsourcing
BioStable: BioStable Science Announces First Commercial Use of the HAART 200 Aortic Annuloplasty Device
Sep 26, 2017
BioSpace
BioStable: BioStable Science & Engineering Announces The First Commercial Use Of The HAART 200 Aortic Annuloplasty Device
BioStable Science & Engineering Competitors
1
2
3
4
5
6
7
8
9
10